Fig. 3From: A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell RepertoireMelanoma patients immunized with NDV oncolysates demonstrate increased oligoclonality in the CD8 compartment compared with age-matched controls.Back to article page